🇺🇸 FDA
Patent

US 7326570

Induction of tubular morphogenesis using pleiotrophin

granted A61KA61K35/22A61K38/18

Quick answer

US patent 7326570 (Induction of tubular morphogenesis using pleiotrophin) held by The Regents of the University of California expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K35/22, A61K38/18, A61K38/1825, A61K38/185